The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis.

Jia-Chun Ma,Jing-Xin Zhang,Fei Wang,Jinming Yu,Dawei Chen

Frontiers in immunology（2022）

引用 1|浏览7

暂无评分

摘要

This study showed that immunotherapy conferred survival benefits on patients with oligometastatic NSCLC. Our subgroup analysis suggested that patients with oligometastatic NSCLC in the brain or multiple organs may particularly benefit from aggressive front-line therapies.

查看译文

关键词

immunotherapy,metastatic sites,non-small cell lung cancer,oligometastases,overall survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要